The Sovereign States Drug Consortium (SSDC) is a collaborative group of Medicaid states. Collectively members are focused on providing quality pharmaceutical care while controlling costs.

The primary activity of the SSDC is a Medicaid drug rebate program that negotiates for rebates that are in addition to those required under the federal Medicaid Drug Rebate Program. The SSDC also provides a forum for Member States to cooperate in other areas of pharmacy benefit administration and management in Medicaid and other publicly funded pharmacy benefit programs. One such project is a diabetic supply rebate program.

Change Healthcare is the SSDC’s current supplemental rebate negotiator and has managed the SSDC negotiation process since 2006. For more information on Change Healthcare, see

For more information about the SSDC and its programs and activities, see: